KL2 Training Program

Current & Past Scholars

The following are brief biographies of the scholars selected for each award year. As you can see, they represent broad disciplinary diversity and bring impressive and relevant training and experience to the CASE/Cleveland Clinic CTSC KL2.

Cohort 1 (2005) | Cohort 2 (2006) | Cohort 3 (2007) | Cohort 4 (2008) | Cohort 5 (2009)
| Cohort 6 (2010) | Cohort 7 (2011) | Cohort 8 (2012) | Cohort 9 (2013) | Cohort 10 (2014) | Cohort 11 (2015) | Cohort 12 (2016)

Cohort 9 (2013)

Charlie Bark
Charlie Bark received his BS degree from Cornell University and completed his MD at the Albert Einstein College of Medicine in the Bronx, New York. He did his residency training in internal medicine as well as a fellowship in infectious diseases at University Hospitals, MetroHealth Medical Center, and the Cleveland VA medical Center. During his fellowship he completed an MS in epidemiology with a focus on surrogate outcomes used in clinical trials of tuberculosis. He recently joined the staff at MetroHealth Medical Center in the Division of Infectious Diseases as an Assistant Professor of Medicine and incoming director of the Cuyahoga Tuberculosis Clinic. He also serves as a principal investigator for Case Western Reserve University's research site for the CDC's Tuberculosis Trials Consortium. As a KL2 scholar, Dr. Bark's research will focus on TB clinical trials and the development of new biomarkers of TB treatment outcome.

Gürkan Bebek
Dr. Gürkan Bebek received a BS in Computer Engineering from Bilkent University, Turkey. He came to Case Western Reserve University (CWRU) to pursue graduate studies at the Electrical Enginnering and Computer Science Department in the field of computational biology and bioinformatics. His doctoral work was centered on identifying signaling pathways by integrating multiple -omic datasets and novel data mining approaches from protein-protein interaction networks. After completing his PhD, he was awarded the NCI funded Training in Computational Genomic Epidemiology of Cancer (CoGEC) postdoctoral fellowship, where he received transdisciplinary training at the intersection of cancer research, epidemiology, biostatistics, genetics, and computer science. Following his postdoctoral training at Case Comprehensive Cancer Center, Dr. Bebek joined the Center for Proteomics and Bioinformatics at CWRU as a faculty member in 2011. As a KL2 Clinical Research Scholar, Dr. Bebek is investigating colorectal cancer driver genes and studying their synergistic activity in tumor development utilizing novel algorithms that are developed by his lab. Dr. Bebek is an Instructor at the Center for Proteomics and Bioinformatcs at CWRU and a Visiting Scientist at the Genomic Medicine Institute at the Cleveland Clinic.

Robyn Busch
Dr. Busch received a BA in Psychology and an MA in Clinical Psychology from California State University, Northridge. She completed a PhD in Clinical Psychology at the University of Cincinnati and an internship in Clinical Neuropsychology at the James A. Haley Veteran's Hospital in Tampa, Florida. Dr. Busch came to Cleveland Clinic as a postdoctoral fellow in Clinical Neuropsychology and was later hired as a Staff Neuropsychologist in the Cleveland Clinic Epilepsy Center. Dr. Busch's past clinical research has focused primarily on identifying factors that contribute to cognitive morbidity in patients with epilepsy and improving prediction of cognitive outcome following epilepsy surgery.

She has a particular interest in investigating the role of genetic factors in the neurobehavioral (including both cognition and behavior) outcomes of epilepsy. As a KL2 Clinical Research Scholar, Dr. Busch will explore the role of several candidate genes in cognition in patients with pharmacoresistant temporal lobe epilepsy and, using whole genome sequencing, seek to identify other genes that may be related to cognitive performance and postsurgical cognitive outcome in these patients

Jacqueline Chen
Jacqueline is a postdoctoral fellow in the Department of Neurosciences at the Cleveland Clinic. She completed a B.Sc. joint major in Physics and Physiology at McGill University, Montreal, Quebec, Canada. For her M.Eng. in Biomedical Engineering at McGill, she designed a fully automated system to quantify in vivo magnetic resonance spectroscopy data and metabolite recovery kinetics in patients with mitochondrial disease. She then undertook a visiting research assistantship at the Oxford Centre for Functional MRI of the Brain, Oxford, UK, where she worked on image processing of MRI to quantify brain volume loss in patients with multiple sclerosis (MS). She returned to McGill for her Ph.D. in Biomedical Engineering, which focused on MRI image processing methods for measuring brain injury, repair and degeneration in patients with MS. She has industry-based experience in software design, documentation, training, planning of MRI visits and the metrics to be evaluated for clinical trials of MS therapeutics. She came to the Cleveland Clinic, attracted by the unique postmortem MRI/rapid autopsy program for MS research, to do her postdoctoral work to develop a clinically feasible method to detect cortical demyelination that is not visible by conventional MRI. As a KL2 Clinical Research Scholar, Jacqueline is establishing a research program for Amyotrophic Lateral Sclerosis that includes in vivo MRI, as well as postmortem MRI and rapid autopsy for histopathological analyses. This program will identify disease mechanisms and therapeutic targets for new treatments as well as appropriate MRI metrics for evaluation of efficacy in clinical trials.

Jarrod Dalton
Jarrod earned his BS in mathematics, computer science, and business from Muskingum University in 2002 and proceeded to earn a master's degree in applied statistics from the University of Michigan in 2003. In 2013, Jarrod received the Doctoral Excellence Award in Biomedical Sciences from Case Western Reserve University for his 2013 Ph.D. thesis in epidemiology and biostatistics. In nearly seven years as a biostatistician within the Cleveland Clinic Departments of Quantitative Health Sciences and Outcomes Research, Jarrod gained expertise in the design and analysis of clinical trials in the area of perioperative medicine and in conducting observational analyses of large, diverse electronic health data registries. His research is focused on using modern electronic health record technology to better support individualized care, primarily through the use of statistical data mining or machine learning techniques. Under the KL2 program, he is working under the mentorship of Neal Dawson, MD to build and validate clinical decision rules which will recommend a treatment alternative for specific conditions according to patients individual comorbidity profiles using large population health databases. He is also working to develop methodology for modeling abnormally low and/or high treatment outcomes, with applications in clinical and translational medicine, health economics, and personalized care.

Doug Gunzler
Dr. Gunzler received a BA in English, also taking substantial psychology coursework, from Emory University. He worked in journalism and book publishing. He interned for the Census Bureau, then worked for the Survey of Income and Program Participation (SIPP) Branch, examining sampling and design issues with big data, while finishing a Master's degree in Statistics at Rutgers University. His doctoral work at the University of Rochester in the Department of Biostatistics & Computational Biology was centered on developing structural equation modeling (SEM) theory and methods by proposing a new class of distribution-free models for mediation analyses in longitudinal data. After completing his PhD, he joined the Center for Health Care Research & Policy at MetroHealth Medical Center. As a KL2 Clinical Research Scholar, Dr. Gunzler is studying depression issues in multiple sclerosis (MS) patients using SEM methods, in conjunction with the Cleveland Clinic's Knowledge Program. Dr. Gunzler is a member of the Biostatistics & Evaluation Unit in the Center for Health Care Research & Policy and Senior Instructor in the Department of Medicine at CWRU.

Robin Jump
Dr. Jump earned both her M.D. and Ph.D. at Case Western Reserve University through the Medical Scientist Training Program. Building upon her graduate work in gut mucosal immunology, she began to investigate nosocomial diarrhea caused by C. difficile during her residency in Internal Medicine at University Hospitals Cleveland Medical Center under the mentorship of Dr. Curtis Donskey. After completing her Fellowship in Infectious Diseases, Dr. Jump joined the Geriatric Research Education and Clinical Center (GRECC) at the Louis Stokes Cleveland Veterans Affairs Medical Center. Her long-term academic interests are to decrease the adverse effects of antimicrobials in older adults. She is a T. Franklin Williams Scholar and received a Young Investigator Award in Geriatrics from the Infectious Disease Society of America Education and Research Foundation/National Foundation for Infectious Diseases. Her research has been supported by a Grant for Early Medical & Surgical Subspecialists Transition to Aging Research (GEMSSTAR) from the NIH and an unrestricted grant from the Steris Foundation. Dr. Jump's research goal as a CWRU VA Clinical Research Scholar is to identify microbiological or metabolic markers that correspond with recovery of the gut microbiome's ability to protect the host from C. difficile infection following a exposure to systemic antibiotics.

Susannah Rose
Susannah Rose an Assistant Professor at Cleveland Clinic Lerner College of Medicine, Case Western University and an Associate Professional Staff member at the Clinic in the Department of Bioethics, with secondary appointments at Taussig Cancer Institute and the Medicine Institute. She received her PhD from Harvard University's Health Policy Program in 2010, earned an MS in Bioethics from Union College/Albany Medical Center in 2006, and earned an MS in Social Work from Columbia University in 1998. She studied Philosophy and Psychology at Furman University, graduating in 1996. Before studying at Harvard, Dr. Rose worked as a clinician and researcher at Memorial Sloan-Kettering Cancer Center in New York City, specializing in the psychosocial issues surrounding cancer. While at Harvard, she received multiple awards and fellowships: Dr. Rose was a National Institute of Mental Health (NIMH) pre-doctoral research fellow; a Harvard Edmond J. Safra Center for Ethics Graduate Fellow; a Safra post-doctoral lab fellow; and she was also a pre- and post doctoral fellow at Massachusetts General Hospital, sponsored by the National Cancer Institute (NCI) through the Program in Cancer Research Outcomes Training (PCORT). She also received multiple teaching awards and the Joan P. Curhan Citizenship Award. She has published two books focused on coping with cancer, and she has published and presented in numerous academic venues on topics related to conflicts of interest in medicine, health policy, oncology and bioethics. While at Cleveland Clinic, Dr. Rose's research has focused upon two primary areas: 1) in conflicts of interest (COI), and 2) in outcomes in end-of-life care. Since arriving at the Clinic, Dr. Rose has received external foundation funding to support her research, and has published several papers, including one as a co-author in the "New England Journal of Medicine" on COI. In the KL2 program, Dr. Rose will be refining and evaluating a new model of end-of-life care, called Palliative Partnership. This model integrates standard outpatient clinical treatment with Palliative Medicine, early in the disease trajectory for people diagnosed with advanced diseases.